Technical Analysis for SCPH - scPharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Fell Below 50 DMA | Bearish | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Bullish Engulfing | Bullish | -5.83% | |
Crossed Above 20 DMA | Bullish | -5.83% | |
Crossed Above 50 DMA | Bullish | -5.83% | |
Expansion Pivot Buy Setup | Bullish Swing Setup | -5.83% | |
Pocket Pivot | Bullish Swing Setup | -5.83% | |
Wide Range Bar | Range Expansion | -5.83% |
Alert | Time |
---|---|
Up 2% | about 17 hours ago |
Up 1% | about 17 hours ago |
Possible Inside Day | about 18 hours ago |
50 DMA Support | about 19 hours ago |
10 DMA Support | about 20 hours ago |
Get a Trading Assistant
- Earnings date: 03/13/2024
scPharmaceuticals Inc. Description
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Drugs Medication Pharmaceutical Products Chemical Compounds Antibiotics Heart Failure Chloroarenes Injection Intravenous Fluids Intravenous Therapy
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.7311 |
52 Week Low | 4.63 |
Average Volume | 240,513 |
200-Day Moving Average | 6.90 |
50-Day Moving Average | 5.63 |
20-Day Moving Average | 5.72 |
10-Day Moving Average | 5.55 |
Average True Range | 0.42 |
RSI (14) | 47.09 |
ADX | 22.58 |
+DI | 20.15 |
-DI | 15.30 |
Chandelier Exit (Long, 3 ATRs) | 5.29 |
Chandelier Exit (Short, 3 ATRs) | 6.20 |
Upper Bollinger Bands | 6.29 |
Lower Bollinger Band | 5.16 |
Percent B (%b) | 0.29 |
BandWidth | 19.67 |
MACD Line | -0.04 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0358 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.23 | ||||
Resistance 3 (R3) | 6.30 | 6.12 | 6.10 | ||
Resistance 2 (R2) | 6.12 | 5.94 | 6.09 | 6.06 | |
Resistance 1 (R1) | 5.81 | 5.82 | 5.72 | 5.74 | 6.02 |
Pivot Point | 5.63 | 5.63 | 5.59 | 5.60 | 5.63 |
Support 1 (S1) | 5.32 | 5.45 | 5.23 | 5.25 | 4.96 |
Support 2 (S2) | 5.14 | 5.33 | 5.11 | 4.92 | |
Support 3 (S3) | 4.83 | 5.14 | 4.88 | ||
Support 4 (S4) | 4.76 |